Zhi Jian Chen
Directeur/Bestuurslid bij Shanghai Haihe Biopharma Co., Ltd.
Actieve functies van Zhi Jian Chen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 01-01-2018 | - |
Huatai Futures Co., Ltd.
 Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Directeur/Bestuurslid | 28-12-2010 | - |
Loopbaan van Zhi Jian Chen
Eerdere bekende functies van Zhi Jian Chen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DELUXE FAMILY CO., LTD. | Directeur/Bestuurslid | 23-08-2010 | 31-05-2012 |
| Algemeen Adviseur | 23-08-2010 | 31-05-2012 | |
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Directeur/Bestuurslid | 06-01-2012 | 06-01-2012 |
Statistieken
Internationaal
| China | 5 |
Operationeel
| Director/Board Member | 4 |
| General Counsel | 1 |
Sectoraal
| Finance | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DELUXE FAMILY CO., LTD. | Finance |
| Bedrijven in privébezit | 3 |
|---|---|
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Finance |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
Huatai Futures Co., Ltd.
Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Finance |
- Beurs
- Insiders
- Zhi Jian Chen
- Ervaring
